암센터 국문 논문 목록
책임저자
제1저자 |
저자,논문명,학술지명,발간일;년도;페이지:통권(Impact Factor) |
김학균
(표적치료연구과)
|
김학균:서민정:정진희, 박한나, 김서영, 최유리, 최슬기, 함승민, 김혜란, 서호경. Novel syngeneic model of anti-mouse CLDN18.2 CAR -T therapy for gastric cancer demonstrates a synergy with TGF-β and PD-L1 inhibitors
MOLECULAR THERAPY ONCOLOGY. 2025-12-17; 2025;
34(1):201120~.
IF 5.3 (2024)
|
서민정
(종양면역연구과)
|
정종휘
(방사선종양학과)
|
정종휘:Byongsu Choi, Deepak K. Shrestha:이성욱, 김종은. Deep learning-based dose prediction for prostate cancer with empty bladder protocol: a framework for efficient and personalized radiotherapy planning
FRONTIERS IN ONCOLOGY. 2025-12-17; 2025;
15:1690416~.
IF 3.3 (2024)
|
Byongsu Choi, Deepak K. Shrestha
|
엄방울
(암진료향상연구과)
|
엄방울:Ji Ho Park, In Cho:류근원, 김영우, 홍경만, 국명철. Feasibility of sentinel basin mapping after non-curative endoscopic resection for early gastric cancer: a prospective multicenter cohort study (SENORITA 2 trial)
INTERNATIONAL JOURNAL OF SURGERY. 2025-12-16; 2025;
:~.
IF 10.3 (2024)
|
Ji Ho Park, In Cho
|
이은경3
(외과)
|
이은경3:박봄비:한재홍, 정소연, 이시연, 강한성, 김시내, 권영미. Reoperation Versus Dose-Escalated Radiotherapy for Ductal Carcinoma In Situ at the Surgical Margin After Breast-Conserving Surgery for Invasive Ductal Carcinoma
JOURNAL OF BREAST CANCER. 2025-12-15; 2025;
28(6):381~392.
IF 2.4 (2024)
|
박봄비
|
최원영
(암분자생물학연구과)
공선영
(표적치료연구과)
|
최원영, 공선영:최원영, 이기연:. Activation of the STING pathway potentiates the antitumor efficacy of doxorubicin in soft-tissue sarcoma
FRONTIERS IN ONCOLOGY. 2025-12-12; 2025;
15:1634503~.
IF 3.3 (2024)
|
최원영
(암분자생물학연구과)
이기연
(표적치료연구과)
|
김정현
(암전이연구과)
|
김정현:최상아, 강지은:. Alternative Splicing-Mediated Resistance to Antibody-Based Therapies: Mechanisms and Emerging Therapeutic Strategies
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025-12-10; 2025;
26(24):11918~.
IF 4.9 (2024)
|
최상아
(암전이연구과)
강지은
(암전이연구과)
|
정진수
(종양면역연구과)
|
정진수:이형호:김민규, 송기현, 정재영, 서호경. Long-Term Cancer Incidence Trends in Korea (2001-2020): An Age-Period-Cohort and Joinpoint Analysis with a Focus on Younger Cohorts
MEDICINA-LITHUANIA. 2025-12-08; 2025;
61(12):2179~.
IF 2.4 (2024)
|
이형호
(비뇨기암센터)
|
심재갈
(암전이연구과)
김용연
(암전이연구과)
|
심재갈, 김용연:성지영, 유하은:김수미, 유수연, 박상원, 임가은, 이병일, 윤경실. Narciclasine as a potential therapeutic agent to overcome EGFR-TKI resistance in non-small cell lung cancer
JOURNAL OF TRANSLATIONAL MEDICINE. 2025-12-05; 2025;
23(1):1380~.
IF 7.5 (2024)
|
성지영
(암전이연구과)
유하은
(암전이연구과)
|
Maya Zeineddine
|
Maya Zeineddine:김호진:. Expert consensus on the clinical use of cladribine tablets for treating relapsing multiple sclerosis in the asia-pacific region
MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2025-12-04; 2025;
105:106897~.
IF 2.9 (2024)
|
김호진
(종양면역연구과)
|
김미경
(암역학연구과)
최성원
(희귀ㆍ소아암연구과)
|
김미경, 최성원:김성민, Zeba Praveen:김연희, 고재희, 최용석, 박주용, 이종호. Functional profiling of the oral microbiome reveals microbial and oncogenic signatures in never-smoking female patients with oral squamous cell carcinoma
JOURNAL OF ORAL MICROBIOLOGY. 2025-12-04; 2025;
17(1):2594842~.
IF 5.5 (2024)
|
김성민
(구강악안면외과)
|
